KATIE DUMAS: Open Payments
NPI 1326896754 · NORMAN, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$441 in 24 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $116 · 2025 $441
Food & beverage: $441
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 5 | $86 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $77 |
| SANOFI PASTEUR INC. | 3 | $56 |
| ABBVIE INC. | 2 | $45 |
| Novo Nordisk Inc | 2 | $30 |
| Boston Scientific Corporation | 1 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
| Almatica Pharma LLC | 1 | $20 |
| Lilly USA, LLC | 1 | $20 |
| Amgen Inc. | 1 | $19 |
Products named: FANAPT, JARDIANCE, UBRELVY, MENQUADFI, Wegovy, WATCHMAN Access System, GEMTESA, TERIPARATIDE.
Industry payments across OK — which companies pay providers there.
